Article Details

Boost to Enhertu's prospects as FDA clears Roche diagnostic - pharmaphorum

Retrieved on: 2025-02-02 21:10:02

Tags for this article:

Click the tags to see associated articles and topics

Boost to Enhertu's prospects as FDA clears Roche diagnostic - pharmaphorum. View article details on hiswai:

Excerpt

Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up